One Step at a Time: An Intervention to Reduce Sedentary Behavior Among Working Adults
NCT ID: NCT05281978
Last Updated: 2023-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2022-04-25
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduce Sedentary Behavior at Work
NCT03816150
Increasing Workplace Physical Activity in Sedentary Office Workers
NCT01846013
Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women
NCT03558828
A "Stand Up and Move More" Intervention for Older Adults
NCT03412084
Modifying the Workplace to Decrease Sedentary Behavior and Improve Health
NCT02376504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Decrease Sedentary Time + Increase MVPA
Participants in this group will receive a 12-week, social cognitive theory-based intervention targetting reduction of daily sedentary time. This information will be delivered to them in the form of Zoom workshops, a program workbook, personalized step count goals, and a private social media page. The aim of this component will be to have participants displace their daily sedentary time with light-intensity physical activity, such as casual walking. The second component of this intervention will be increasing participants' weekly MVPA engagement. Participants will participate in 1 live, virtual aerobics-based exercise class per week and complete 2 additional sessions on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).
Decrease Sedentary Time + Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise; personalized step count goals to increase daily volume of physical activity and displacement of sedentary time
Increase MVPA only
Participants in this group will only receive the MVPA-promoting component (which will be the same delivery as the intervention group). Participants in this arm will participate in 1 live, virtual aerobics-based exercise class per week (held separately from the intervention group) and will complete 2 additional exercise classes on their own time. Participants will build up to exercising 150 minutes/week (the federal physical activity recommendations).
Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Decrease Sedentary Time + Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise; personalized step count goals to increase daily volume of physical activity and displacement of sedentary time
Increase MVPA group
12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hold full-time employment (≥ 30 hours/week) at one or more jobs
* Hold a sedentary-based job (which also allows for ability to freely move about during the workday)
* Low active (engage in ≤2 days of 30+ minutes of structured moderate-vigorous intensity exercise/week)
* Physician's consent to participate in aerobic testing and/or the exercise program (if needed based on Physical Activity Readiness Questionnaire responses)
* Ambulatory
* Absence of health conditions that may be made worse by exercise
* Ability to complete all testing assessments in-person
* Access to a laptop/desktop/phone with Zoom web-conferencing software
* Fluent in English
Exclusion Criteria
* Not holding full-time employment (work \< 30 hours/week at one or more jobs)
* Hold a job(s) which is classified as light, medium, heavy, or very heavy work
* Hold a sedentary-based job which does not allow for free movement throughout the workday (i.e., bus driver)
* High active (engage in \> 2 days or 30+ minutes of structured moderate-vigorous intensity exercise/week)
* Non-consent of physician
* Non-ambulatory (i.e., use of walkers, wheelchair, cane, etc.)
* Presence of health conditions that may be made worse by exercise.
* Unable to complete assessments in-person
* No access to laptop/desktop/phone with Zoom software
45 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Urbana-Champaign
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neha P Gothe, MA, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Urbana-Champaign
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Illinois Urbana-Champaign
Urbana, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22651
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.